Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about SNY

Recent news which mentions SNY

< Previous 1 2
...
22 23 24 25 26 27 28 29 Next >
Allowing people to mix COVID-19 vaccines could cut into Pfizer and Moderna’s revenue next year
Tickers AZN BNTX JNJ MRNA
Tags SNY UK:AZN SNYNF
From MarketWatch
3 Biotech Stocks That Surged in September
Tickers BGNE BLU KDMN LPTX
Tags BGNE LPTX BLU
From Motley Fool
After COVID-19, Could This Be the Next Billion-Dollar Vaccine Market?
Tickers ARCT BNTX MRNA PFE
Tags MRNA BNTX PFE
From Motley Fool
Here's a High-Yield Dividend Stock Wall Street Thinks Could Jump 26% Within 12 Months
Tickers GSK SNY
Tags Market News SNY GSK
From Motley Fool
This Healthcare Company Is Using AI to Develop Drugs
Tickers BMY GILD SDGR SNY
Tags Market News SNY TAK
From Motley Fool
Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates
Tickers ANIP AVDL BHC CALT
Tags MNKD EYEN CCXI
From Benzinga
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
Tickers LLY NVO PHG RMD
Tags PHG LLY RMD
From Motley Fool
Can These Former Biotech Growth Stocks Regain Their Form?
Tickers ACAD AZN CLVS HRTX
Tags CLVS SNY HRTX
From Motley Fool
Hopes rise that Pfizer COVID-19 vaccine will be authorized for use in children aged 5 to 11 by late October, and Russia suffers worst one-day death toll
Tickers BNTX MRNA PFE SNY
Tags MRNA BNTX PFE
From MarketWatch
The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive
Tickers AFIB ALT AMZN APYX
Tags PASG GBT ESALY
From Benzinga
Sanofi Stops Work On Its mRNA COVID-19 Vaccine: What You Need To Know
Tickers BNTX GSK MRNA PFE
Tags GSK Briefs General
From Benzinga
3 Big Pharma Stocks Wall Street Thinks Could Soar By At Least 30%
Tickers BMY CRSP REGN SNY
Tags Market News REGN SNY
From Motley Fool
Analyst Upgrades Sanofi On COVID-19 Vaccine Optimism
Tickers GSK SNY
Tags pharmaceuticals Analyst Ratings Covid/19
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2021
Tickers ABNB ACHC AGL AHCO
Tags NATI Intraday Update JXN
From Benzinga
3 Top Biotech Stocks to Buy for the Long Haul
Tickers ABBV AMGN AZN JNJ
Tags AMGN SNY Market News
From Motley Fool
Acceleron In Advanced $11B Buyout Talks: Bloomberg
Tickers AMGN BMY GILD MRK
Tags Health Care AMGN BMY
From Benzinga
Sanofi, Regeneron, Share Competitive Libtayo Survival Data in 1L NSCLC
Tickers REGN SNY
Tags Benzinga SNY Health Care
From Benzinga
Here's Why Moderna's Stock Could Crash Before the End of 2021
Tickers AZN GSK JNJ MRNA
Tags GSK PFE SNY
From Motley Fool
5 COVID Vaccine Stocks With Late-Stage Candidates You'll Want to Watch
Tickers DVAX GSK INO NVAX
Tags GSK DVAX NVAX
From Motley Fool
AbbVie's Pain Is Sanofi's and Regeneron's Gain
Tickers ABBV PFE REGN SNY
Tags PFE SNY Market News
From Motley Fool
The Week Ahead In Biotech (Sept. 12-18): Calliditas FDA Decision, Adcom Review For Pfizer/BioNTech COVID-19 Vaccine, Oncology Conference And IPOs
Tickers ALRN AZN BIIB BNTX
Tags Market News CALT PRCT
From Benzinga
These Promising Clinical Results Could Be Huge for Amgen Investors
Tickers ABBV AMGN AZN GSK
Tags SNY Market News ABBV
From Motley Fool
Can Pfizer Beat Sanofi and Regeneron in the Eczema Market?
Tickers PFE REGN SNY
Tags SNY Market News REGN
From Motley Fool
3 Stocks to Watch in September
Tickers ABBV CRLBF GOOG GOOGL
Tags GOOGL ABBV Market News
From Motley Fool
Could This Be Pfizer's Next Blockbuster Vaccine?
Tickers BMY BNTX GSK JNJ
Tags BNTX JNJ GSK
From Motley Fool
EMA Gives Nod To Additional Sites For Pfizer - BioNTech COVID-19 Vaccine
Tickers BNTX PFE SNY
Tags Movers COVID/19 Coronavirus Market News
From Benzinga
Could This Label Expansion Be a Blockbuster for AbbVie's Shareholders?
Tickers ABBV LLY PFE REGN
Tags Market News REGN SNY
From Motley Fool
2 Top Healthcare Stocks That Could Boost Your Portfolio in September (and Beyond)
Tickers HCA LLY NVO SNY
Tags LLY SNY Market News
From Motley Fool
Sanofi's BTK Inhibitor Disappoints In Phase 3 Autoimmune Disease Trial
Tickers SNY
Tags News Phase 3 Trial Biotech
From Benzinga
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
Tickers ABSI ABT AZN BIVI
Tags EW LLY NUVL
From Benzinga
< Previous 1 2
...
22 23 24 25 26 27 28 29 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.